Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia-Reference-Cited by-同舟云学术

Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia

Published:2021-07-15 Issue:3 Volume:59 Page:239-254
ISSN:1995-4492
Container-title:Rheumatology Science and Practice
language:
Short-container-title:Naučno-praktičeskaâ revmatologiâ

Author:

Nasonov E. L.¹^ORCID,Lila A. M.²^ORCID,Mazurov V. I.³^ORCID,Belov B. S.⁴^ORCID,Karateev A. E.⁴^ORCID,Dubinina T. V.⁴^ORCID,Nikitinskaya O. A.⁴^ORCID,Baranov A. A.⁵,Abdulganieva D. I.⁶^ORCID,Moiseev S. V.⁷^ORCID,Zagrebneva A. I.⁸^ORCID

Affiliation:

1. V.A. Nasonova Research Institute of Rheumatology; I.M. Sechenov First Moscow State Medical University of the Ministry of Health Care of Russian Federation (Sechenov University)

2. V.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation

3. North-Western State Medical University named after I.I. Mechnikov

4. V.A. Nasonova Research Institute of Rheumatology

5. Yaroslavl State Medical University of the Ministry of Health of Russia

6. Kazan State Medical University

7. I.M. Sechenov First Moscow State Medical University of the Ministry of Health Care of Russian Federation (Sechenov University)

8. Russian National Research Medical University by N.I. Pirogova

Abstract

In mid-2021, the SARS-CoV-2 (Severe Acute Respiratory coronavirus 2) infection, which caused the coronavirus disease (COVID-19) pandemic, affected more than 157 million people in all regions of the world and led to more than 3.2 million deaths. It is assumed that elderly age, uncontrolled inflammation, anti-inflammatory therapy, comorbid pathology, genetic and other factors can potentially lead to an increase in “sensitivity” to viral and bacterial infections, including SARS-CoV-2. The new version of the recommendations of the Association of Rheumatologists of Russia formulates the main provisions concerning the tactics of managing patients with Immune-mediated Rheumatic Diseases during the ongoing COVID-19 pandemic.

Publisher

Mediar Press

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference179 articles.

1. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9

2. World Health Organization. Coronavirus Disease (COVID-2019). Situation Reports (World Health Organization, 2020).

3. Nasonov EL. Coronavirus Disease 2019 (COVID-19): A rheumatologist’s thoughts. Nauchcno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(2):123-132 (In Russ.). doi: 10.14412/1995-4484-2020-123-132

4. Nasonov EL. Coronavirus disease 2019 (COVID-19) and autoimmunity. Nauchcno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2021;59(1):5-30 (In Russ.). doi: 10.47360/1995-4484-2021-5-30

5. Nasonov EL, Beketova TV, Reshetnyak TM, Lila AM, Ananieva LP, Lisitsyna TA, et al. Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity. Nauchcno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(4):353-367 (In Russ.). doi: 10.47360/1995-4484-2020-353-367

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in patients with rheumatic diseases: frequency and course;Medical alphabet;2024-07-21

2. Results of a 12-Week Open-Label, Non-Interventional Study of the Efficacy and Safety of Olokizumab Therapy in Patients with Rheumatoid Arthritis after Switching from Anti-B-Cell Therapy during the SARS-CoV-2 Pandemic;Doklady Biochemistry and Biophysics;2024-07-01

3. Results of a 24-week open-label, non-interventional study on the efficacy and safety of olokizumab therapy in patients with rheumatoid arthritis after switching from anti-B-cell therapy during the SARS-CoV-2 pandemic;Modern Rheumatology Journal;2024-06-14

4. Achievements of rheumatology in the XXI century: contribution of Russian rheumatology;Clinical Medicine (Russian Journal);2024-06-01

5. Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects;Rheumatology Science and Practice;2024-02-29